申请人:Harbin Zhenbao Pharmaceutical Co., Ltd.
公开号:EP3333157A1
公开(公告)日:2018-06-13
FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.
提供了表皮生长因子受体(FGFR)和血管内皮生长因子受体(VEGFR)抑制剂,并特别公开了作为表皮生长因子受体(FGFR)和血管内皮生长因子受体(VEGFR)抑制剂的式(1)或式(II)所代表的化合物、其药学上可接受的盐或同系物。